Drinking Water Quality Tied to Lung Infections in Patients With Cystic Fibrosis
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 1, 2023 -- Naturally occurring and anthropogenic water-quality constituents may heighten the risk for nontuberculous mycobacterial (NTM) pulmonary disease in people with cystic fibrosis, according to a study published in the October issue of Environmental Epidemiology.
Ettie M. Lipner, from the U.S. National Institutes of Health in Bethesda, Maryland, and colleagues identified water-quality constituents that influence the risk for NTM pulmonary infection in persons with cystic fibrosis in the United States. Data from the Cystic Fibrosis Foundation Patient Registry (2010 to 2019) were linked to surface water data extracted from the Water Quality Portal for each patient ZIP code.
The researchers identified 484 Mycobacterium avium complex (MAC) cases, 222 Mycobacterium abscessus cases, and 2,816 NTM-negative cystic fibrosis controls living in 11 states. For every standardized unit increase in the log concentration of sulfate and vanadium in surface water at the county level, the odds of infection increased by 39 and 21 percent, respectively, among persons with cystic fibrosis with MAC versus cystic fibrosis-NTM-negative controls. For M. abscessus, every standardized unit increase in the log concentration of molybdenum increased the odds of infection by 36 percent.
“While more research is needed to confirm our results in other geographic regions of the United States, these findings may be useful to inform susceptible patients of their risks in residing in specific regions,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up
WEDNESDAY, May 1, 2024 -- There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase, according to a study...
Multisite QI Collaborative Increases Appropriate Pediatric Antibiotic Use
MONDAY, April 29, 2024 -- A multisite collaborative increases appropriate antibiotic use for pediatric community-acquired pneumonia, skin and soft tissue infections, and urinary...
ACP: Next-Generation Antibiotics Underused for Gram-Negative Infections
MONDAY, April 22, 2024 -- Clinicians frequently treat gram-negative infection with older, generic antibiotics, despite recent approval of next-generation, gram-negative...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.